Expression of dawScer\UAS.cSa under the control of Scer\GAL4Cg.PA results in less than 10% lethality.
Scer\GAL4Cg.PA, dawUAS.cSa has some die during P-stage phenotype, enhanceable by Scer\GAL4Cg.PA/tokUAS.cSa.Tag:HA
Scer\GAL4A9, baboc.UAS, dawUAS.cSa, tokUAS.cSa.Tag:HA has visible phenotype
Scer\GAL4A9, baboc.UAS, dawUAS.cSa, tokUAS.cSa.Tag:HA has wing vein phenotype
Expression of dawScer\UAS.cSa and tokScer\UAS.cSa.T:Ivir\HA1 in the wing under the control of Scer\GAL4A9 does not result in any wing vein-patterning defects.
Expression of baboc.Scer\UAS, dawScer\UAS.cSa and tokScer\UAS.cSa.T:Ivir\HA1 in the wing under the control of Scer\GAL4A9 results in a severe wing vein-patterning defects.
Co-expression of dawScer\UAS.cSa, baboa.Scer\UAS and babob.Scer\UAS in the wing under the control of Scer\GAL4A9 does not result in wing vein patterning defects.
Coexpression of tokScer\UAS.cSa.T:Ivir\HA1 and dawScer\UAS.cSa, under the control of Scer\GAL4Cg.PA results in over 50% pupal lethality, as opposed to under 10% in Scer\GAL4Cg.PA>dawScer\UAS.cSa animals and no lethality in Scer\GAL4Cg.PA>tokScer\UAS.cSa.T:Ivir\HA1 animals.